SANA Investors Have Opportunity to Lead Sana Biotechnology, Inc. Securities Fraud Lawsuit with the Schall Law Firm – Sana Biotechnology (NASDAQ:SANA)
LOS ANGELES, April 7, 2025 /PRNewswire/ — The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sana Biotechnology, Inc. (“Sana” or “the Company”) SANA for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 …